SCHEMBL21297318

SCHEMBL21297318

c1cc2nc3ccc4nc5c6nc7ccc8nc9ccc%10nc%11ccc%12nc%13c%14nc%15ccc%16nc%17ccc%18nc%19ccc%20nc%21c%22nc%23ccc%24nc1c1nc%24c%23nc%22c%22nc%23c%24nc%22c%21nc%20c%19nc%18c%17nc%16c%15nc%14c%14nc%24c%15nc%14c%13nc%12c%11nc%10c9nc8c7nc6c6nc%15c%23nc6c5nc4c3nc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.40
ALDH1A1 P00352 5/20 0.40
RAB9A P51151 4/20 0.40
GAA P10253 2/20 0.40
KMT2A Q03164 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
ACHE P22303 2/20 0.39
NQO2 P16083 9/20 0.36
THRB P10828 2/20 0.35
BLM P54132 2/20 0.35
KDM4E B2RXH2 2/20 0.35
NPC1 O15118 2/20 0.35
MAPK1 P28482 1/20 0.35
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
POLB P06746 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
MEN1 O00255 1/20 0.32
CASP6 P55212 1/20 0.32
GLA P06280 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4654883 0.80 MAPT (0.69) MAPTALDH1A1RAB9AGAAKMT2A
SCHEMBL15499536 0.68 CCR1 (0.39) MAPTALDH1A1RAB9AGAAKMT2A
SCHEMBL31391239 0.67 MYC (0.63) MAPTALDH1A1RAB9AGAAKMT2A
SCHEMBL8206153 0.67 MAPT (0.48) MAPTALDH1A1RAB9AGAAKMT2A
SCHEMBL11202171 0.67 MAPT (0.62) MAPTALDH1A1RAB9AGAANQO2
SCHEMBL2246928 0.67 MAPT (0.71) MAPTALDH1A1RAB9AGAAKMT2A
SCHEMBL15498000 0.67 CCR1 (0.47) MAPTALDH1A1RAB9AGAAKMT2A
SCHEMBL29402115 0.67 MAPT (0.71) MAPTALDH1A1RAB9AGAAKMT2A
SCHEMBL29581806 0.67 MAPT (0.71) MAPTALDH1A1RAB9AGAAKMT2A
SCHEMBL5473804 0.66 PRMT5 (0.59) MAPTALDH1A1RAB9AACHENQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10392395-B2 Nitrogen-containing aromatic compounds and metal complexes SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2019-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10392395-B2 Nitrogen-containing aromatic compounds and metal complexes TYR, MT-CO2, SOD1 MAPT 1832/4885ALDH1A1 2123/4885RAB9A 2799/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.